- Home
- SUPN vs STC Comparison
SUPN vs STC Comparison
Compare SUPN & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | STC |
|---|---|---|
| Founded | 2005 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.1B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | SUPN | STC |
|---|---|---|
| Price | $51.32 | $69.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $61.60 | ★ $81.50 |
| AVG Volume (30 Days) | ★ 609.5K | 263.2K |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.96% |
| EPS Growth | N/A | ★ 69.60 |
| EPS | N/A | ★ 3.60 |
| Revenue | $681,539,000.00 | ★ $2,796,513,000.00 |
| Revenue This Year | $8.32 | $17.67 |
| Revenue Next Year | $23.36 | $10.14 |
| P/E Ratio | ★ N/A | $19.73 |
| Revenue Growth | 4.54 | ★ 16.09 |
| 52 Week Low | $29.16 | $56.39 |
| 52 Week High | $57.65 | $78.61 |
Technical Indicators
Market Signals| Indicator | SUPN | STC |
|---|---|---|
| Relative Strength Index (RSI) | 62.79 | 38.32 |
| Support Level | $47.80 | $68.69 |
| Resistance Level | $52.30 | $72.15 |
| Average True Range (ATR) | 1.44 | 1.84 |
| MACD | -0.03 | -0.21 |
| Stochastic Oscillator | 78.22 | 11.38 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.